Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details)

v2.4.0.8
STOCKHOLDERS' EQUITY (Details)
 0 Months Ended 3 Months Ended 3 Months Ended
Feb. 05, 2014
Mar. 31, 2014
Mar. 31, 2014
Warrant One [Member]
Mar. 31, 2014
Warrant Two [Member]
Mar. 31, 2014
Warrant Three [Member]
Mar. 31, 2014
Warrant Three [Member]
Minimum [Member]
Mar. 31, 2014
Warrant Three [Member]
Maximum [Member]
Mar. 31, 2014
February 2014 Private Placement [Member]
Mar. 31, 2014
February 2013 Public Offering [Member]
Mar. 31, 2014
February 2013 Public Offering - Placement Agents [Member]
Mar. 31, 2014
November 2012 Private Placement [Member]
Mar. 31, 2014
June 2012 Public Offering [Member]
Mar. 31, 2014
December 2011 Underwritten Offering [Member]
Mar. 31, 2014
April 2011 Private Placement [Member]
Class of Warrant or Right [Line Items]                            
Number Of Shares Issuable Upon Exercise Of Outstanding Warrants (in shares)   39,282,459 27,310 [1] 105,040 91,524     8,000,000 [2] 11,000,000 [1] 770,000 1,000,000 2,981,440 9,248,334 6,058,811
Warrants Exercise Price (in dollars per share)     0.50 [1] 16.065   99.45 100.98 1.00 [2] 0.50 [1] 0.625 1.25 1.25 0.60 0.75
Warrants Expiration Date Feb. 06, 2019   Jul. 27, 2015 [1] Jul. 27, 2015 Dec. 31, 2015     Feb. 06, 2019 [2] Feb. 20, 2018 [1] Feb. 04, 2018 Nov. 02, 2017 Jun. 13, 2017 Dec. 06, 2016 Mar. 31, 2016
[1] The exercise prices of these warrants are subject to adjustment for “down-rounds” and the warrants have been accounted for as a derivative instrument as described in Note 2.
[2] Warrants issued in connection with the sale of convertible debentures. As described in Note 3, the warrants are only exercisable following conversion of the associated debentures.